Primary cutaneous B-cell lymphoma: How useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?

British Journal of Dermatology

Volumn 139, Issue 6, 1998, Pages 945-949

  Russell Jones, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CANCER CLASSIFICATION; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SKIN LYMPHOMA;

CHROMOSOME ABERRATIONS; GENOTYPE; HUMANS; LYMPHOMA, B-CELL; SKIN NEOPLASMS;

EID: 0032423129     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02547.x     Document Type: Review

References (25)

1. Norton A. Classification of non-Hodgkin's lymphoma In Non-Hodgkin's Lymphoma. (Linch D, ed.) Balliéres Clinical Haematology, Vol. 9, London: Balliére Tindall. 1996: 641-52.
2. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
3. Society for Haematopathology Program. Proposed World Health Organisation classification of neoplastic diseases of haematopoietic and lymphoid tissues. Am J Surg Pathol 1997; 21: 114-21.
4. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas. Blood 1997; 90: 345-71.
5. Medeiros L, van Krieken J, Jaffe E, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990; 76: 2086-90.
6. Vandenberghe E, De Wolf-Peeters C, Van den Oord J et al. Translocation (11:14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991; 163: 13-18.
7. Tsujimoto T, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-43.
8. McDonnell T, Deane N, Platt F et al. Bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 1989; 57: 79-88.
9. Cooper K, Haffajee Z. Bcl-2 immunohistochemistry distinguishes follicular lymphoma from follicular hyperplasia in formalin-fixed tissue with microwave antigen retrieval. J Cell Pathol 1996; 1: 52-6.
10. Delia D, Borrello M, Berti E et al. Clonal immunoglobulin gene rearrangements and normal T-cell receptors, bcl-2 and c-myc genes in primary cutaneous B-cell lymphomas. Cancer Res 1989; 49: 4901-5.
11. Snow J, Peters M, Muller S, Kurtin P. Primary cutaneous B-cell lymphoma, secondary cutaneous B-cell lymphoma and cutaneous B-cell pseudolymphoma. A histological, immunohistochemical and molecular genetics analysis of 73 cases. J Cutan Pathol 1993; 20: 573.
12. Slater DN. MALT and SALT: the clue to cutaneous B-cell lympho-proliferative disease. Br J Dermatol 1994; 131: 557-61.
13. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Cancer 1991; 67: 2311-26.
14. Gianotti B, Santucci M. Skin associated lymphoid tissue (SALT)-related B-cell lymphoma (primary cutaneous B-cell lymphoma). Arch Dermatol 1993; 129: 353-5.
15. Willemze R, Beljaards R, Meijer C, Rijlaarsdam J. Classification of primary cutaneous lymphomas: historical overview and perspectives. Dermatology 1994; 189 (Suppl. 2): 8-15.
16. Willemze R, Rijlaarsdan J, Meiyer C. Are most primary cutaneous B-cell lymphomas marginal zone lymphomas? Br J Dermatol 1995; 133: 950-4.
17. Kim B, Norton A, Calonje G et al. Is cutaneous immunocytoma a variant of marginal zone lymphoma? Modern Pathol 1998; 11: 50A (Abstr.)
18. Vermco M, Becler F, Haselen C et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 1996; 132: 1304-8.
19. Pimpinelli N, Santucci M, Mori M et al. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity? J Am Acad Dermatol 1997; 37: 1012-16.
20. Geeler F, Belijaards R, Van der Putte S, Willemze R. Differences in the expression of bcl-2 protein and adhesion molecules between prognostically different groups of primary cutaneous large B-cell lymphomas. Ann Oncol 1996; 7 (Suppl. 3): 132 (Abstr.).
21. 11 gene rearrangement in a primary cutaneous lymphoma by micromanipulation and single-cell PCR. J Invest Dermatol 1997; 109: 541-5.
22. Cerroni L, Minkus G, Putz B et al. Laser beam microdissection in the diagnosis of cutaneous B-cell lymphoma. Br J Dermatol 1997; 136: 743-6.
23. Cerroni L, Volkenandt M, Rieger E et al. Bcl-2 Protein expression and correlation with the interchromosomal 14:18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994; 102: 231-5.
24. Sepp N, Haun M, Sidoroff A et al. Loss of translocation (T 14:18) in nodal follicular (CB/cc) non-Hodgkin lymphomas (NHL) might be associated with a risk of cutaneous involvement. Abstracts of the meeting of the European Organization for Research and Treatment of Cancer (cutaneous lymphoma group), Munich, 1996.
25. Pezzella F, Santucci M, Neri A et al. Bcl-2 gene rearrangement and protein expression in primary cutaneous B-cell lymphomas. In Basic Mechanisms of Physiological and Aberrant Lymphoproliferation in the Skin (NATO AS1 Series: Series A, Life Sciences) (van Vloten WA, Lambert WC, Giannotti B eds.) New York: Plenum Press: 1994; 343-53.